6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
14m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
40m ago	CPKC increases dividend by 17.5 percent
41m ago	Waldencast announces conclusion of SEC investigation
41m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Eledon Pharmaceuticals Inc (NASDAQ:ELDN) — investor relations, events, news, and company updates on 6ix.

Latest News

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference

Financials

Revenue

$0

Market Cap

$244.47 M

EPS

-0.52

Community Chat

Ask AI